Back
NRX Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
NRXP
NRX Pharmaceuticals
Last Price:
1.26
Seasonality Move:
44.75%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRXP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NRX Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.23 | Buy |
| 20-day SMA: | 1.28 | Sell |
| 50-day SMA: | 1.4 | Sell |
| 200-day SMA: | 2.88 | Sell |
| 8-day EMA: | 1.24 | Buy |
| 20-day EMA: | 1.27 | Sell |
| 50-day EMA: | 1.43 | Sell |
| 200-day EMA: | 2.62 | Sell |
NRX Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 46.49 | Sell |
| Chaikin Money Flow: | 51053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.21 - 1.33) | Sell |
| Bollinger Bands (100): | (1.33 - 2.15) | Sell |
NRX Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NRX Pharmaceuticals Stock
Is NRX Pharmaceuticals Stock a Buy?
- NRX Pharmaceuticals share price is 1.26 while NRXP 8-day simple moving average is 1.23, which is a Buy signal.
- The stock price of NRXP is 1.26 while NRX Pharmaceuticals 20-day SMA is 1.28, which makes it a Sell.
- NRX Pharmaceuticals 50-day simple moving average is 1.40 while NRXP share price is 1.26, making it a Sell technically.
- NRXP stock price is 1.26 and NRX Pharmaceuticals 200-day simple moving average is 2.88, creating a Sell signal.
NRXP Technical Analysis vs Fundamental Analysis
Sell
45
NRX Pharmaceuticals (NRXP)
is a Sell
Is NRX Pharmaceuticals a Buy or a Sell?
-
NRX Pharmaceuticals stock is rated a Sell
The current NRX Pharmaceuticals [NRXP] share price is $1.26. The Score for NRXP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
NRX Pharmaceuticals Stock Info
Market Cap:
15.24M
Price in USD:
1.26
Share Volume:
76.58K
NRX Pharmaceuticals 52-Week Range
52-Week High:
7.33
52-Week Low:
1.10
Sell
45
NRX Pharmaceuticals (NRXP)
is a Sell
NRX Pharmaceuticals Share Price Forecast
-
What is the NRX Pharmaceuticals stock price today?
The NRX Pharmaceuticals stock price is 1.26 USD today. -
Will NRXP stock go up or go down?
NRX Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NRX Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NRX Pharmaceuticals is overvalued.
Is NRX Pharmaceuticals Stock a Buy?
- NRX Pharmaceuticals share price is 1.26 while NRXP 8-day exponential moving average is 1.24, which is a Buy signal.
- The stock price of NRXP is 1.26 while NRX Pharmaceuticals 20-day EMA is 1.27, which makes it a Sell.
- NRX Pharmaceuticals 50-day exponential moving average is 1.43 while NRXP share price is 1.26, making it a Sell technically.
- NRXP stock price is 1.26 and NRX Pharmaceuticals 200-day simple moving average is 2.62, creating a Sell signal.
Fundamental Analysis of NRX Pharmaceuticals
Is NRX Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and an increase next year of $1.17 per share.
Technical Analysis of NRX Pharmaceuticals
Should I short NRX Pharmaceuticals stock?
- NRXP Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting NRX Pharmaceuticals is a Sell
- NRX Pharmaceuticals Relative Strength Index (RSI) is 46.49, which suggest NRX Pharmaceuticals is oversold
- The Bollinger Bands (25) for NRX Pharmaceuticals is (1.21 - 1.33), which suggest NRX Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NRX Pharmaceuticals is (1.33 - 2.15), which suggest NRX Pharmaceuticals is a Sell
* NRX Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.